• 中国中文核心期刊
  • 中国科学引文数据库核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
高级检索

基于生物可降解高分子的蛋白类药物纳米递送系统研究进展

陈星, 康洋, 吴钧

陈星, 康洋, 吴钧. 基于生物可降解高分子的蛋白类药物纳米递送系统研究进展[J]. 中国药科大学学报, 2017, 48(2): 142-149. DOI: 10.11665/j.issn.1000-5048.20170203
引用本文: 陈星, 康洋, 吴钧. 基于生物可降解高分子的蛋白类药物纳米递送系统研究进展[J]. 中国药科大学学报, 2017, 48(2): 142-149. DOI: 10.11665/j.issn.1000-5048.20170203
CHEN Xing, KANG Yang, WU Jun. Advances in biodegradable functional polymers based protein drug delivery system[J]. Journal of China Pharmaceutical University, 2017, 48(2): 142-149. DOI: 10.11665/j.issn.1000-5048.20170203
Citation: CHEN Xing, KANG Yang, WU Jun. Advances in biodegradable functional polymers based protein drug delivery system[J]. Journal of China Pharmaceutical University, 2017, 48(2): 142-149. DOI: 10.11665/j.issn.1000-5048.20170203

基于生物可降解高分子的蛋白类药物纳米递送系统研究进展

Advances in biodegradable functional polymers based protein drug delivery system

  • 摘要: 生物可降解功能高分子纳米载药粒子具有良好的生物相容性,作为新型药物载体在疾病的诊断和治疗方面显示出巨大的应用价值。蛋白类药物最近在肿瘤免疫疗法及其他重大疾病中大放异彩,但是其载体技术的发展却相对滞后。本文从蛋白类药物递送方面综述了近年来生物可降解功能高分子作为蛋白类药物纳米载体的研究进展,并对开发具有更好应用研究前景的新型生物可降解功能高分子进行了展望。
    Abstract: Biodegradable and biocompatible functional polymers show high potential as novel drug carriers in disease diagnosis and therapy. Recently, protein drugs have brought about major breakthroughs in the treatment of various diseases including cancer, while the development of carrier technology is relatively delayed. This article reviews recent advances in biodegradable functional polymers as protein drug nanocarriers. Additionally, we have discussed the perspective of developing new generations of biocompatible and functional polymers.
  • [1] Pakulska MM,Miersch S,Shoichet MS.Designer protein delivery:from natural to engineered affinity-controlled release systems[J].Science,2016,351(6279):aac4750.
    [2] Vermonden T, Censi R, Hennink WE. Hydrogels for protein delivery[J].Chem Rev, 2012,112(5):2853-2888.
    [3] Zhao M,Biswas A,Hu B,et al.Redox-responsive nanocapsules for intracellular protein delivery[J].Biomaterials,2011,32(22):5223-5230.
    [4] Gu Z,Biswas A,Zhao M,et al.Tailoring nanocarriers for intracellular protein delivery[J].Chem Soc Rev,2011,40(7):3638-3655.
    [5] Su ZG,Mo R,Zhang C.Advances of nano-drug delivery systems overcoming the physiological and pathological barriers of tumor[J].J China Pharm Univ(中国药科大学学报),2015,46(1):28-39.
    [6] Liu Q,Zuo Q,Guo R,et al.Fabrication and characterization of carboxymethyl chitosan/poly(vinyl alcohol)hydrogels containing alginate microspheres for protein delivery[J].J Bioact Compat Pol,2015,30(4):397-411.
    [7] Mo R,Sun Q,Li N,et al.Intracellular delivery and antitumor effects of pH-sensitive liposomes based on zwitterionic oligopeptide lipids[J].Biomaterials,2013,34(11):2773-2786.
    [8] Faria PCB,Santos LI,Coelho JP,et al.Oxidized multiwalled carbon nanotubes as antigen delivery system to promote superior CD8+ T cell response and protection against cancer[J].Nano Lett,2014,14(9):5458-5470.
    [9] Shen H,Liu M,He H,et al.PEGylated graphene oxide-mediated protein delivery for cell function regulation[J].ACS Appl Mater Interfaces,2012,4(11):6317-6323.
    [10] Morimoto N,Hirano S,Takahashi H,et al.Self-assembled pH-sensitive cholesteryl pullulan nanogel as a protein delivery vehicle[J].Biomacromolecules,2012,14(1):56-63.
    [11] Liang K,Ng S,Lee F,et al.Targeted intracellular protein delivery based on hyaluronic acid-green tea catechin nanogels[J].Acta Biomater,2016,33:142-152.
    [12] Kamaly N,Xiao Z,Valencia PM,et al.Targeted polymeric therapeutic nanoparticles:design,development and clinical translation[J].Chem Soc Rev,2012,41(7):2971-3010.
    [13] Shi J,Xiao Z,Kamaly N,et al.Self-assembled targeted nanoparticles:evolution of technologies and bench to bedside translation[J].Acc Chem Res,2011,44(10):1123-1134.
    [14] Bertrand N,Wu J,Xu X,et al.Cancer nanotechnology:the impact of passive and active targeting in the era of modern cancer biology[J].Nat Rev Drug Discov,2014,66:2-25.
    [15] Kamaly N,Yameen B,Wu J,et al.Degradable controlled-release polymers and polymeric nanoparticles:mechanisms of controlling drug release[J].Chem Rev,2016,116(4):2602-2663.
    [16] Danhier F,Ansorena E,Silva JM,et al.PLGA-based nanoparticles:an overview of biomedical applications[J].J Controlled Release,2012,161(2):505-522.
    [17] Mahapatro A,Singh DK.Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines[J].J Nanobiotechnol,2011,9(55):1-11.
    [18] Kumirska J,Weinhold MX,Thöming J,et al.Biomedical activity of chitin/chitosan based materials—influence of physicochemical properties apart from molecular weight and degree of N-acetylation[J].Polymers,2011,3(4):1875-1901.
    [19] Zhang H,Wu S,Tao Y,et al.Preparation and characterization of water-soluble chitosan nanoparticles as protein delivery system[J].J Nanomater,2010,2010:1-5.
    [20] Panyam J,Labhasetwar V.Biodegradable nanoparticles for drug and gene delivery to cells and tissue[J].Adv Drug Deliv Rev,2003,55(3):329-347.
    [21] Rietscher R,Czaplewska JA,Majdanski TC,et al.Impact of PEG and PEG-b-PAGE modified PLGA on nanoparticle formation,protein loading and release[J].Int J Pharm,2016,500(1):187-195.
    [22] Chopra S,Lim JM,Karnik R,et al.Role of electrostatic interactions in protein loading in PLGA-PEG nanoparticles[C].Bioengineering Conference(NEBEC),2014 40th Annual Northeast.IEEE,2014:1-2.
    [23] Kim S,Kim YS.Production of gliadin-poly(ethyl cyanoacrylate)nanoparticles for hydrophilic coating[J].J Nanopart Res,2014,16(2):1-10.
    [24] Papadimitriou SA, Achilias DS, Bikiaris DN. Chitosan-g-PEG nanoparticles ionically crosslinked with poly(glutamic acid)and tripolyphosphate as protein delivery systems[J].Int J Pharm,2012,430(1):318-327.
    [25] Zhou P,An T,Zhao C,et al.Lactosylated PLGA nanoparticles containing ε-polylysine for the sustained release and liver-targeted delivery of the negatively charged proteins[J].Int J Pharm,2015,478(2):633-643.
    [26] Bakhru SH,Furtado S,Morello AP,et al.Oral delivery of proteins by biodegradable nanoparticles[J].Nat Rev Drug Discov,2013,65(6):811-821.
    [27] Veiseh O,Tang BC,Whitehead KA,et al.Managing diabetes with nanomedicine:challenges and opportunities[J].Nat Rev Drug Discov,2015,14(1):45-57.
    [28] Shan W,Zhu X,Liu M,et al.Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin[J].ACS Nano,2015,9(3):2345-2356.
    [29] Ryan E,Grice JE,Roberts MS.Nanotechnology for Topical and Transdermal Drug Delivery and Targeting[M]//Nanotechnology and Drug Delivery,Volume Two:Nano-Engineering Strategies and Nanomedicines against Severe Diseases.CRC Press,2016:75-101.
    [30] Mitragotri S,Burke PA,Langer R.Overcoming the challenges in administering biopharmaceuticals:formulation and delivery strategies[J].Nat Rev Drug Discov,2014,13(9):655-672.
    [31] Bernocchi B,Carpentier R,Lantier I,et al.Mechanisms allowing protein delivery in nasal mucosa using NPL nanoparticles[J].J Controlled Release,2016,232:42-50.
    [32] Wu J,Kamaly N,Shi J,et al.Development of multinuclear polymeric nanoparticles as robust protein nanocarriers[J].Angew Chem Int Ed,2014,53(34):8975-8979.
    [33] Zhu X,Wu J,Shan W,et al.Polymeric nanoparticles amenable to simultaneous installation of exterior targeting and interior therapeutic proteins[J].Angew Chem Int Ed,2016,55(10):3309-3312.
    [34] Radovic-Moreno AF,Lu TK,Puscasu VA,et al.Surface charge-switching polymeric nanoparticles for bacterial cell wall-targeted delivery of antibiotics[J].ACS Nano,2012,6(5):4279-4287.
    [35] Mo R,Jiang T,Di J,et al.Emerging micro-and nanotechnology based synthetic approaches for insulin delivery[J].Chem Soc Rev,2014,43(10):3595-3629.
    [36] Gu Z,Aimetti AA,Wang Q,et al.Injectable nano-network for glucose-mediated insulin delivery[J].ACS Nano,2013,7(5):4194-4201.
    [37] Silva JM,Videira M,Gaspar R,et al.Immune system targeting by biodegradable nanoparticles for cancer vaccines[J].J Controlled Release,2013,168(2):179-199.
    [38] Rahimian S, Kleinovink JW, Fransen MF, et al. Near-infrared labeled,ovalbumin loaded polymeric nanoparticles based on a hydrophilic polyester as model vaccine: in vivo tracking and evaluation of antigen-specific CD8+ T cell immune response[J].Biomaterials,2015,37:469-477.
计量
  • 文章访问数:  1096
  • HTML全文浏览量:  1
  • PDF下载量:  3450
  • 被引次数: 0
出版历程
  • 刊出日期:  2017-04-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭